Your browser version may not work well with NCBI's Web applications. More information here...
1: Bioorg Med Chem Lett. 2001 Feb 12;11(3):319-21.Click here to read Links

The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective alpha7 nicotinic receptor partial agonist.

Macor JE, Gurley D, Lanthorn T, Loch J, Mack RA, Mullen G, Tran O, Wright N, Gordon JC.

AstraZeneca, Three Biotech, Worcester, MA 01605, USA. john.macor@bms.com

The 5-HT3 receptor antagonist tropisetron (ICS 205-930) was found to be a potent and selective partial agonist at alpha7 nicotinic receptors. Two other 5-HT3 receptor antagonists, ondansetron and LY-278,584, were found to lack high affinity at the alpha7 nicotinic receptor. Quinuclidine analogues (1 and 2) of tropisetron were also found to be potent and selective partial agonists at alpha7 nicotinic receptors.

PMID: 11212100 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Ondansetron (Zofran® , ZofranODT® )

    Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy and surgery. Ondansetron is in a class of medications called 5-HT3 receptor antagonists. It works by blocking the action...

  • Aprepitant (Emend, Anzemet, Kytril, ...)

    How do newer antiemetics compare in preventing nausea and vomiting?

  • Source: AHFS Consumer Medication Information